Suppr超能文献

颈动脉疾病中的血清生物标志物

Serum Biomarkers in Carotid Artery Disease.

作者信息

Kigka Vassiliki I, Potsika Vassiliki, Mantzaris Michalis, Tsakanikas Vassilis, Koncar Igor, Fotiadis Dimitrios I

机构信息

Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece.

Department of Vascular and Endovascular Surgery, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

出版信息

Diagnostics (Basel). 2021 Nov 18;11(11):2143. doi: 10.3390/diagnostics11112143.

Abstract

Carotid artery disease is considered a major cause of strokes and there is a need for early disease detection and management. Although imaging techniques have been developed for the diagnosis of carotid artery disease and different imaging-based markers have been proposed for the characterization of atherosclerotic plaques, there is still need for a definition of high-risk plaques in asymptomatic patients who may benefit from surgical intervention. Measurement of circulating biomarkers is a promising method to assist in patient-specific disease management, but the lack of robust clinical evidence limits their use as a standard of care. The purpose of this review paper is to present circulating biomarkers related to carotid artery diagnosis and prognosis, which are mainly provided by statistical-based clinical studies. The result of our investigation showed that typical well-established inflammatory biomarkers and biomarkers related to patient lipid profiles are associated with carotid artery disease. In addition to this, more specialized types of biomarkers, such as endothelial and cell adhesion, matrix degrading, and metabolic biomarkers seem to be associated with different carotid artery disease outputs, assisting vascular specialists in selecting patients at high risk for stroke and in need of intervention.

摘要

颈动脉疾病被认为是中风的主要原因,因此需要早期疾病检测和管理。尽管已经开发了成像技术用于诊断颈动脉疾病,并且已经提出了不同的基于成像的标志物来表征动脉粥样硬化斑块,但对于可能从手术干预中获益的无症状患者,仍需要定义高危斑块。循环生物标志物的测量是一种有前景的方法,可协助进行针对患者的疾病管理,但缺乏有力的临床证据限制了它们作为标准治疗手段的应用。这篇综述文章的目的是介绍与颈动脉诊断和预后相关的循环生物标志物,这些标志物主要来自基于统计的临床研究。我们的调查结果表明,典型的、已确立的炎症生物标志物以及与患者血脂谱相关的生物标志物与颈动脉疾病有关。除此之外,更特殊类型的生物标志物,如内皮和细胞黏附、基质降解和代谢生物标志物,似乎与不同的颈动脉疾病结果相关,有助于血管专科医生选择中风高危且需要干预的患者。

相似文献

1
Serum Biomarkers in Carotid Artery Disease.颈动脉疾病中的血清生物标志物
Diagnostics (Basel). 2021 Nov 18;11(11):2143. doi: 10.3390/diagnostics11112143.
2
Review of serum biomarkers in carotid atherosclerosis.颈动脉粥样硬化的血清标志物研究综述。
J Vasc Surg. 2020 Jan;71(1):329-341. doi: 10.1016/j.jvs.2019.04.488. Epub 2019 Jul 18.
5
MR imaging of vulnerable carotid plaque.易损性颈动脉斑块的磁共振成像
Cardiovasc Diagn Ther. 2020 Aug;10(4):1019-1031. doi: 10.21037/cdt.2020.03.12.
10
Molecular imaging of carotid plaque vulnerability.颈动脉斑块易损性的分子成像
Cerebrovasc Dis. 2015;39(1):5-12. doi: 10.1159/000369123. Epub 2014 Dec 24.

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验